The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,504.00
Bid: 12,504.00
Ask: 12,506.00
Change: 100.00 (0.81%)
Spread: 2.00 (0.016%)
Open: 12,500.00
High: 12,514.00
Low: 12,444.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Jefferies cuts Persimmon; BoA cuts GSK

Mon, 05th Dec 2022 10:00

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

Bank of America cuts Vodafone price target to 130 (140) pence - 'neutral'

----------

Bank of America cuts BT Group price target to 187 (223) pence - 'buy'

----------

Bank of America cuts GSK to 'underperform' (neutral) - price target 1,450 (1,640) pence

----------

Bank of America raises AstraZeneca price target to 14,500 (12,500) pence - 'buy'

----------

Bernstein cuts Reckitt Benckiser price target to 6,100 (6,400) pence - 'market-perform'

----------

Bernstein cuts Unilever to 'market-perform' (outperform) - price target 3,500 (4,280) pence

----------

RBC raises Compass Group price target to 1,625 (1,575) pence - 'underperform'

----------

JPMorgan raises B&M price target to 555 (414) pence - 'overweight'

----------

JPMorgan raises Sainsbury price target to 206 (161) pence - 'underweight'

----------

JPMorgan raises Tesco price target to 270 (240) pence - 'overweight'

----------

Jefferies raises Barratt Developments price target to 452 (356) pence - 'hold'

----------

Jefferies cuts Persimmon to 'hold' (buy) - price target 1,436 (1485) pence

----------

Jefferies raises Taylor Wimpey price target to 124 (105) pence - 'buy'

----------

Jefferies raises Berkeley Group price target to 4,554 (4,330) pence - 'buy'

----------

Jefferies raises CRH price target to 51.60 (50.30) EUR - 'buy'

----------

Jefferies cuts Spirax-Sarco price target to 9,910 (11,460) pence - 'underperform'

----------

FTSE 250

----------

Bank of America raises Helios Towers price target to 180 (175) pence - 'buy'

----------

Morgan Stanley cuts Hays price target to 145 (146) pence - 'overweight'

----------

Morgan Stanley cuts PageGroup to 'equal-weight' (overweight) - price target 505 (510) pence

----------

UBS raises easyJet price target to 600 (565) pence - 'buy'

----------

Jefferies raises Travis Perkins price target to 931 (811) pence - 'hold'

----------

Jefferies raises Redrow price target to 592 (491) pence - 'buy'

----------

Jefferies raises Crest Nicholson price target to 278 (229) pence - 'buy'

----------

Jefferies raises Vistry price target to 829 (744) pence - 'buy'

----------

Jefferies raises Bellway to 'buy' (hold) - price target 2,458 (1,928) pence

----------

SMALL CAP

----------

Citigroup cuts Gamma Communications price target to 1,320 (1,650) pence - 'buy'

----------

Berenberg raises Tharisa price target to 260 (240) pence - 'buy'

----------

Deutsche Bank cuts Ferguson price target to 9,630 (9,960) pence - 'hold'

----------

Barclays raises AIB price target to 3.80 (3.40) EUR - 'equal weight'

----------

Jefferies cuts Watkin Jones to 'hold' (buy) - price target 111 (225) pence

----------

Jefferies cuts Kingspan to 'underperform' (hold) - price target 45.90 (63.60) EUR

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.